» Articles » PMID: 20069056

A Multifactorial Mechanism in the Superior Antimalarial Activity of Alpha-C-GalCer

Overview
Specialty Biology
Date 2010 Jan 14
PMID 20069056
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously shown that the C-glycoside analog of alpha-galactosylceramide (alpha-GalCer), alpha-C-GalCer, displays a superior inhibitory activity against the liver stages of the rodent malaria parasite Plasmodium yoelii than its parental glycolipid, alpha-GalCer. In this study, we demonstrate that NK cells, as well as IL-12, are a key contributor for the superior activity displayed by alpha-C-GalCer. Surprisingly, the diminished production of Th2 cytokines, including IL-4, by alpha-C-GalCer has no affect on its superior therapeutic activity relative to alpha-GalCer. Finally, we show that the in vivo administration of alpha-C-GalCer induces prolonged maturation of dendritic cells (DCs), as well as an enhanced proliferative response of mouse invariant Valpha14 (Valpha14i) NKT cells, both of which may also contribute to some degree to the superior activity of alpha-C-GalCer in vivo.

Citing Articles

Can invariant Natural Killer T cells drive B cell fate? a look at the humoral response.

Palacios P, Santibanez A, Aguirre-Munoz F, Gutierrez-Vera C, Nino de Zepeda-Carrizo V, Gongora-Pimentel M Front Immunol. 2025; 16:1505883.

PMID: 40040714 PMC: 11876049. DOI: 10.3389/fimmu.2025.1505883.


Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis.

Yang J, Zhou Y, Singh R J Immunol Res. 2016; 2016:2395645.

PMID: 27563682 PMC: 4987483. DOI: 10.1155/2016/2395645.


Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators.

Bergmann-Leitner E, Leitner W Vaccines (Basel). 2015; 2(2):252-96.

PMID: 26344620 PMC: 4494256. DOI: 10.3390/vaccines2020252.


Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.

Guillaume J, Pauwels N, Aspeslagh S, Zajonc D, Elewaut D, Van Calenbergh S Bioorg Med Chem. 2015; 23(13):3175-82.

PMID: 26003341 PMC: 4461518. DOI: 10.1016/j.bmc.2015.04.068.


Boosting the Immune Response: The Use of iNKT cell ligands as vaccine adjuvants.

Subrahmanyam P, Webb T Front Biol (Beijing). 2012; 7(5):436-444.

PMID: 23264781 PMC: 3524977. DOI: 10.1007/s11515-012-1194-2.


References
1.
Yang G, Schmieg J, Tsuji M, Franck R . The C-glycoside analogue of the immunostimulant alpha-galactosylceramide (KRN7000): synthesis and striking enhancement of activity. Angew Chem Int Ed Engl. 2004; 43(29):3818-22. DOI: 10.1002/anie.200454215. View

2.
Schumann J, Voyle R, Wei B, MacDonald H . Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells. J Immunol. 2003; 170(12):5815-9. DOI: 10.4049/jimmunol.170.12.5815. View

3.
Schmieg J, Gonzalez-Aseguinolaza G, Tsuji M . The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites. Microbes Infect. 2003; 5(6):499-506. DOI: 10.1016/s1286-4579(03)00072-8. View

4.
Singh A, Wilson M, Hong S, Olivares-Villagomez D, Du C, Stanic A . Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med. 2001; 194(12):1801-11. PMC: 2193577. DOI: 10.1084/jem.194.12.1801. View

5.
Gonzalez-Aseguinolaza G, de Oliveira C, Tomaska M, Hong S, Bruna-Romero O, Nakayama T . alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci U S A. 2000; 97(15):8461-6. PMC: 26970. DOI: 10.1073/pnas.97.15.8461. View